Brix

Brix Biopharma is a pharmaceutical and biotechnology company headquartered in Mumbai, India, focused on the research, development, and global distribution of innovative bio-therapeutics and generic medications. Founded in 2019, the company has rapidly expanded its presence to over 17 countries with a massive portfolio of more than 2,000 products across therapeutic areas such as oncology, respiratory care, and infectious diseases. Its innovation core is anchored by an in-house mRNA platform utilized for the development of next-generation vaccines and therapies for life-threatening conditions. Brix Biopharma operates WHO-GMP certified manufacturing facilities and is dedicated to making high-quality, life-saving treatments accessible and affordable on a global scale. By bridging traditional pharmaceutical manufacturing with advanced biotechnology, the company aims to address significant unmet medical needs across three continents.